These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 19833057

  • 21. Redefining response in overactive bladder syndrome.
    Payne CK, Kelleher C.
    BJU Int; 2007 Jan; 99(1):101-6. PubMed ID: 17227496
    [Abstract] [Full Text] [Related]

  • 22. Solifenacin succinate for the treatment of symptoms of overactive bladder.
    Maniscalco M, Singh-Franco D, Wolowich WR, Torres-Colón R.
    Clin Ther; 2006 Sep; 28(9):1247-72. PubMed ID: 17062299
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Emerging drugs for overactive bladder.
    Karmarkar R, Khullar V.
    Expert Opin Emerg Drugs; 2015 Sep; 20(4):613-24. PubMed ID: 26359223
    [Abstract] [Full Text] [Related]

  • 26. Antimuscarinic mechanisms and the overactive detrusor: an update.
    Andersson KE.
    Eur Urol; 2011 Mar; 59(3):377-86. PubMed ID: 21168951
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fesoterodine: a new agent for treating overactive bladder.
    Ellsworth P, Berriman SJ, Brodsky M.
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S115-7. PubMed ID: 19355800
    [Abstract] [Full Text] [Related]

  • 29. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG, Kaplan SA, Jones JS, Wang JT, Bavendam T, Guan Z.
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [Abstract] [Full Text] [Related]

  • 30. Persistence with antimuscarinic therapy in patients with overactive bladder.
    Haab F, Castro-Diaz D.
    Int J Clin Pract; 2005 Aug; 59(8):931-7. PubMed ID: 16033615
    [Abstract] [Full Text] [Related]

  • 31. Lower urinary tract symptoms (LUTS) and bladder afferent activity.
    Yoshimura N.
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):908-13. PubMed ID: 17654565
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fesoterodine for the treatment of overactive bladder.
    Tzefos M, Dolder C, Olin JL.
    Ann Pharmacother; 2009 Dec; 43(12):1992-2000. PubMed ID: 19920160
    [Abstract] [Full Text] [Related]

  • 34. [Medical treatment of voiding problems in men].
    Andersen JT, Nordling J, Walter S.
    Ugeskr Laeger; 2007 May 14; 169(20):1892-4. PubMed ID: 17553364
    [Abstract] [Full Text] [Related]

  • 35. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA, McVary KT.
    Int J Impot Res; 2008 Dec 14; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [Abstract] [Full Text] [Related]

  • 36. The medical treatment of overactive bladder, including current and future treatments.
    Athanasopoulos A, Cruz F.
    Expert Opin Pharmacother; 2011 May 14; 12(7):1041-55. PubMed ID: 21299469
    [Abstract] [Full Text] [Related]

  • 37. Persistence and compliance with medication management in the treatment of overactive bladder.
    Kim TH, Lee KS.
    Investig Clin Urol; 2016 Mar 14; 57(2):84-93. PubMed ID: 26981589
    [Abstract] [Full Text] [Related]

  • 38. [Developments in the medical treatment of overactive bladder].
    Alcántara Montero A.
    Semergen; 2016 Mar 14; 42(8):557-565. PubMed ID: 26671329
    [Abstract] [Full Text] [Related]

  • 39. The promise of beta3-adrenoceptor agonists to treat the overactive bladder.
    Furuta A, Thomas CA, Higaki M, Chancellor MB, Yoshimura N, Yamaguchi O.
    Urol Clin North Am; 2006 Nov 14; 33(4):539-43, x. PubMed ID: 17011390
    [Abstract] [Full Text] [Related]

  • 40. Preclinical compounds for the treatment of overactive bladder.
    Giannitsas K, Konstantinopoulos A, Patsialas C, Athanasopoulos A, Perimenis P.
    Expert Opin Ther Pat; 2009 Feb 14; 19(2):107-17. PubMed ID: 19441912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.